Cyst & Lipoma Excision: Depth Decides the Code Family — and the Pay

The short version

• A superficial cyst is a skin excision (11400 series); a lipoma is a soft-tissue tumor coded from the musculoskeletal family (2xxxx) by region, depth, and size.
• Coding a lipoma as a skin excision is the most common and most expensive error here — a soft-tissue code pays two to four times a skin code.
• Within the soft-tissue family the pivot is depth: subcutaneous versus subfascial (intramuscular), and the subfascial code pays substantially more.
• The size threshold that splits small from large is not the same across the body — it’s 2 cm on the face, 1.5 cm on the hand and foot, and 3 or 5 cm on most of the trunk and extremities.

A cyst is a skin excision; a lipoma is a soft-tissue tumor

Two soft lumps that look alike under the drape code from opposite ends of the CPT book. A superficial epidermal or sebaceous cyst is a skin lesion, excised with the benign-excision codes (11400 series) by measured diameter — the same excised-diameter rule we cover in our benign excision guide. A lipoma is not a skin lesion at all; it’s a soft-tissue tumor of the fat, and it’s coded from the musculoskeletal family (the 2xxxx series) by region, depth, and size.

That distinction is where the money leaks. Excise a thigh lipoma and report it as an 11406 skin excision and you bill roughly $334 for a procedure the soft-tissue code (27337) pays around $408 subcutaneously, or about $714 if it’s deep. Same operation, hundreds of dollars of difference, and the only thing that changed is which family you coded from. The skin codes carry a 10-day global; the soft-tissue codes carry a 90-day global, because they’re classified as the larger procedure they are.

The soft-tissue grid: region, then depth, then size

The soft-tissue excision codes are a grid, and once you see the shape it repeats down the whole body. Each region — face, neck, shoulder, arm, forearm, hand, hip, thigh, leg, foot — carries four codes: subcutaneous below the size split, subcutaneous at or above it, subfascial below, and subfascial at or above. Pick the region, decide the depth, measure against that region’s threshold, and the grid gives you the code.

The dollars climb with both depth and size. A subcutaneous soft-tissue excision runs roughly $324 to $588 depending on region; the subfascial version of the same region runs $480 to $714. Against a benign skin excision’s $128 to $334 (11400 to 11406, trunk and extremity), even the smallest soft-tissue code is a different tier of reimbursement — which is exactly why the tumor has to be documented as a soft-tissue tumor, at its real depth, and not folded into a skin-excision note.

Subcutaneous vs subfascial: the depth that moves the pay

Within a region, depth is the pivot. A subcutaneous tumor sits in the fat above the fascia; a subfascial (intramuscular or deep) tumor sits below it, and reaching it is the more extensive procedure. The subfascial code pays substantially more in every region — a deep neck tumor (21554) runs about $681 against a subcutaneous one (21555) near $463; a deep thigh tumor (27339) reaches about $714.

So the operative note has to state the plane. “Excision of lipoma” without a depth forces a downcode to the cheaper subcutaneous line, or an outright denial when the claim can’t support the code billed. Document whether you went above or below the fascia, because that one word decides which half of the region’s grid you’re in.

The size thresholds that move by region

The last variable is size, and the trap is assuming one cutoff. The threshold that separates the small code from the large one is set per region: 2 cm on the face and scalp, 1.5 cm on the hand and foot, and 3 cm subcutaneous / 5 cm subfascial across most of the trunk and extremities. A 2.5 cm hand lipoma is “large”; a 2.5 cm thigh lipoma is “small.” Same measurement, opposite tier.

Measure the tumor and match it to that region’s threshold, not a remembered number. Between the region, the depth, and the region-specific size split, the grid is fully determined — and every one of those three has to be in the note, or the code you bill won’t be the code the record supports.

What the excision note needs before you bill

A soft-tissue excision claim that holds carries five things: the tumor identified as a soft-tissue tumor (a lipoma, not a “lesion”), the anatomic region, the depth relative to the fascia, the measured size against that region’s threshold, and a covered reason for removal — symptomatic, enlarging, functionally interfering, or diagnostically uncertain. “Patient wanted it removed” reads as cosmetic on a lipoma just as fast as on a skin tag.

The failure mode is quiet: a lipoma excised, documented as a lesion, coded as a skin excision, and paid at a third of its value, on every case. Rates and global days for both code families are a free lookup on Billing IQ. If soft-tissue and lipoma excisions are undercoding across your schedule, our medical billing team works the family selection, the depth capture, and the region-specific sizing behind them.

The 90-day global takes the closure — and modifier 50 only works on half these codes

Moving from a 10-day global to a 90-day global is not just a longer follow-up window. It changes what else you can put on the claim.

The closure splits three ways, and not the way it does on the skin codes. CMS is blunt about the global package: “Closure/repair of a surgical incision is included in the global surgical package. Wound repair CPT codes 12001-13153 shall not be reported separately to describe closure of surgical incisions for procedures with global surgery indicators of 000, 010, 090, or MMM” (NCCI Policy Manual, Chapter IV). On the soft-tissue family that lands in three tiers. Simple closure is included. Intermediate closure is included too — CPT’s musculoskeletal guidelines state that the excision codes include simple or intermediate repair. Complex repair is the one that survives: CPT says extensive undermining or other techniques to close the defect “may require a complex repair, which may be reported separately.” The edit table treats that as a maybe rather than a no. Every soft-tissue code carries a PTP edit against 13100-13153, but the modifier indicator is 1, so it unbundles when the note actually carries the complex-repair work. Put a 12032 next to a 27337 and you are billing a line that was already paid. Put a 13101 next to it with the undermining documented and the modifier on, and it is a $390 line you had been leaving behind.

This is exactly where the two families stop behaving alike. 11406 and 11606 carry no NCCI edit at all against intermediate or complex repair. None. Excise a 2 cm cyst, close it in layers, bill 11406 and 12032, and nothing has to be overridden. The smallest benign codes sit at the opposite end — 11400, 11420 and 11440 “include simple, intermediate, or complex repairs which shall not be reported separately” per NCCI Chapter III. So the same layered closure is a clean separate line on one code, a modifier-and-documentation play on another, and a flat denial on a third. What decides it is the code family, and the code family was decided back at the depth. The skin-side version of this runs through our benign excision guide.

Modifier 50 splits the grid in half. Bilateral billing is not a judgment call, it is a field on the fee schedule. On the CMS Relative Value File, the bilateral surgery indicator is 1 on the paired-limb codes — shoulder (23071, 23073), upper arm (24071, 24073), forearm (25071, 25073), thigh and knee (27327, 27328, 27337, 27339), leg (27618, 27619) and foot (28039, 28041) — which means two sides bill as one line with modifier 50 at 150%. It is 0 on the face, scalp, neck, thorax (21011 through 21556) and, despite the anatomy, on the hand codes (26111 through 26117). Put modifier 50 on a hand or a face code and the line denies. Two hand lipomas get reported by site, not by side.

Generally speaking, the multiple-procedure indicator is 2 across the whole family, so a second soft-tissue excision in the same session pays at 50%. Code it, do not drop it — half of a $590 line is still more than the skin code you were tempted to use instead.

The POS 11 denial is avoidable, and the policy behind it is backwards

Here is the one that eats the most time. You excise a lipoma in your own procedure room, bill it at place of service 11, and the claim comes back denied with CARC 58 — “treatment was deemed by the payer to have been rendered in an inappropriate or invalid place of service.” It reads like an edit misfiring. Generally speaking it is not. Payers write site-of-service policy that pushes 2xxxx excisions out of the office on purpose, and the denial is that policy working as designed.

Now do the arithmetic the payer is doing. In your office the case is one claim. Every code in the grid carries a non-facility rate, which is CMS pricing the procedure for an office — the room, the tray, the staff and the specimen handling are yours, so the payment includes them. Move the same case to an ASC and it becomes two claims: your professional fee, which drops, plus a facility fee to the ASC, which did not exist before. On Medicare’s own numbers — the Physician Fee Schedule for the professional side and the ASC payment rate addenda for the facility side — the second version costs more every time.

Read the last column again. A payer with a site-of-service policy on 26115 is spending $475 more per case to stop you doing it in a room that is already built, staffed and sterile. On 21555 it is $577. The policy does not save the payer money and it does not improve the care; it moves an office excision into a surgical suite and pays a second entity to host it. Same operation, same surgeon, two claims instead of one. The arithmetic runs the same way on any payer that pays a separate facility fee — only the numbers change.

Which brings up the part that actually matters: none of this has to reach your denial queue. A site-of-service policy is published. It is knowable before the patient is on the schedule, for the specific code you are going to bill. Check it at scheduling and there are only two outcomes, and both are fine. The excision goes ahead in the office and gets paid, or it goes to the facility on purpose, with the professional fee and the facility fee both landing where you expected. The version that costs you is the third one — the one where you find out after the case, from a CARC 58, on a claim you cannot rebill.

So the number worth pulling is not the denial count. It is how many of these you do a year, and how many payers on your grid have a site-of-service policy you have never read. The first number is revenue. The second one is how much of it is currently up to chance.

Frequently asked questions

This article explains how these codes tend to get paid — it is not coding, billing, or legal advice. Some of the codes here are bundled into the main procedure, or fall into grey areas that vary by payer. Before billing anything in a grey area, confirm it with your own coding and compliance team and the current guidance from your specialty society, Medicare (CMS), and AMA CPT. When in doubt, don’t bill it.